2nd Quarter - Termination Amendment
FABIANI & COMPANY for IPIERIAN, INC.
Firm
Client
Income
$50,000
Expenses
—
Terminated
Jun 30, 2011
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 20, 2011 | $50,000 | Replaced |
| 2nd Quarter - Termination Amendment (this page) | Oct 20, 2011 | $50,000 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
Secure funding to support drug research and development
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BARROWS | — |
| MELISSA DUPREE | — |
Health Issues HCR
Secure funding to support drug research and development
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BARROWS | — |
| MELISSA DUPREE | — |
Veterans VET
Secure funding to support drug research and development
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BARROWS | — |
| MELISSA DUPREE | — |
Medical/Disease Research/Clinical Labs MED
Secure funding to support drug research and development
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BARROWS | — |
| MELISSA DUPREE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.